<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE ep-patent-document SYSTEM "ep-patent-document-v1-4.dtd">
<ep-patent-document id="EP1414805A1" country="EP" dtd-version="ep-patent-document-v1-4.dtd" doc-number="1414805" date-publ="20040506" file="02791508.1" lang="fr" kind="A1" status="n"><SDOBI lang="fr"><B000><eptags><B001EP>ATBECHDEDKESFRGBGRITLILUNLSEMCPTIESILTLVFIROMKCYALTRBGCZEE....SK................</B001EP><B003EP>*</B003EP><B005EP>X</B005EP><B007EP>DIM350 (Ver 2.1 Jan 2001) 1100000/0 1710000/0</B007EP></eptags></B000><B100><B110>1414805</B110><B130>A1</B130><B140><date>20040506</date></B140><B190>EP</B190></B100><B200><B210>02791508.1</B210><B220><date>20020724</date></B220><B240><B241><date>20040227</date></B241></B240><B250>Fr</B250><B251EP>Fr</B251EP><B260>Fr</B260></B200><B300><B310>0110118</B310><B320><date>20010727</date></B320><B330><ctry>FR</ctry></B330></B300><B400><B405><date>20040506</date><bnum>200419</bnum></B405><B430><date>20040506</date><bnum>200419</bnum></B430></B400><B500><B510><B516>7</B516><B511> 7C 07D 231/56   A</B511><B512> 7C 07D 413/04   B</B512><B512> 7C 07D 209/44   B</B512><B512> 7C 07D 209/36   B</B512><B512> 7A 61K  31/416  B</B512><B512> 7A 61K  31/4035 B</B512><B512> 7A 61K  31/404  B</B512><B512> 7A 61P  35/00   B</B512></B510><B540><B541>de</B541><B542>INDAZOL- ODER INDOLDERIVATE, DEREN VERWENDUNG IN DER HUMANMEDIZIN UND INSBESONDERE IN DER ONKOLOGIE</B542><B541>en</B541><B542>INDAZOLE OR INDOLE DERIVATIVES, THEIR USE IN HUMAN MEDICINE AND MORE PARTICULARLY IN CANCEROLOGY</B542><B541>fr</B541><B542>DERIVES DES INDAZOLES OU DES INDOLES, LEUR UTILISATION EN MEDECINE HUMAINE ET PLUS PARTICULIEREMENT EN CANCEROLOGIE</B542></B540></B500><B700><B710><B711><snm>Aventis Pharma S.A.</snm><iid>00460217</iid><irf>ST 01021</irf><adr><str>20, avenue Raymond Aron</str><city>92160 Antony</city><ctry>FR</ctry></adr></B711></B710><B720><B721><snm>NEMECEK, Conception</snm><adr><str>65 rue Maurepas</str><city>F-94320 Thiais</city><ctry>FR</ctry></adr></B721><B721><snm>MAILLIET, Patrick</snm><adr><str>87 rue Dalayrac</str><city>F-94120 Fontenay Sous Bois</city><ctry>FR</ctry></adr></B721><B721><snm>THOMPSON, Fabienne</snm><adr><str>25 rue Cotte</str><city>F-75012 Paris</city><ctry>FR</ctry></adr></B721><B721><snm>TABART, Michel</snm><adr><str>3 rue Paul Langevin</str><city>F-91290 La Norville</city><ctry>FR</ctry></adr></B721><B721><snm>BACQU , Eric</snm><adr><str>123 allée de la Clairière</str><city>F-91190 Gif Sur Yvette</city><ctry>FR</ctry></adr></B721><B721><snm>WENTZLER, Sylvie</snm><adr><str>10 avenue Garennière</str><city>F-94260 Fresnes</city><ctry>FR</ctry></adr></B721><B721><snm>COMBEAU, Cécile</snm><adr><str>2013 avenue Roger Salengro</str><city>F-92370 Chaville</city><ctry>FR</ctry></adr></B721></B720><B740><B741><snm>Le Pennec, Magali</snm><sfx>et al</sfx><iid>00058357</iid><adr><str>Aventis Pharma S.A.Direction des Brevets,Tri LEO/14420, Avenue Raymond Aron</str><city>92165 Antony Cedex</city><ctry>FR</ctry></adr></B741></B740></B700><B800><B840><ctry>AT</ctry><ctry>BE</ctry><ctry>BG</ctry><ctry>CH</ctry><ctry>CY</ctry><ctry>CZ</ctry><ctry>DE</ctry><ctry>DK</ctry><ctry>EE</ctry><ctry>ES</ctry><ctry>FI</ctry><ctry>FR</ctry><ctry>GB</ctry><ctry>GR</ctry><ctry>IE</ctry><ctry>IT</ctry><ctry>LI</ctry><ctry>LU</ctry><ctry>MC</ctry><ctry>NL</ctry><ctry>PT</ctry><ctry>SE</ctry><ctry>SK</ctry><ctry>TR</ctry></B840><B844EP><B845EP><ctry>AL</ctry><date>20040227</date></B845EP><B845EP><ctry>LT</ctry><date>20040227</date></B845EP><B845EP><ctry>LV</ctry><date>20040227</date></B845EP><B845EP><ctry>MK</ctry><date>20040227</date></B845EP><B845EP><ctry>RO</ctry><date>20040227</date></B845EP><B845EP><ctry>SI</ctry><date>20040227</date></B845EP></B844EP><B860><B861><dnum><anum>FR2002002638</anum></dnum><date>20020724</date></B861><B862>Fr</B862></B860><B870><B871><dnum><pnum>WO2003011833</pnum></dnum><date>20030213</date><bnum>200307</bnum></B871></B870></B800></SDOBI></ep-patent-document>
